Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maurizio, Uva"'
Autor:
Carlo Lazzaro, Cécile van Steen, Giorgio Ghirelli, Matteo Sacchi, Dario Sisto, Maurizio Uva, Luigi Varano, Luigi Angelillo
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 23:251-265
STN1013001 is an innovative latanoprost cationic emulsion for open-angle glaucoma/ocular hypertension (OAG/OHT) and ocular surface disease (OSD). A 5-year, 7 health states, 1-year cycle early Markov model-supported cost-utility analysis (CUA) of STN1
Autor:
Angela Trovato Salinaro, Manuela Pennisi, Rosanna Di Paola, Maria Scuto, Rosalia Crupi, Maria Teresa Cambria, Maria Laura Ontario, Mario Tomasello, Maurizio Uva, Luigi Maiolino, Edward J. Calabrese, Salvatore Cuzzocrea, Vittorio Calabrese
Publikováno v:
Immunity & Ageing, Vol 15, Iss 1, Pp 1-8 (2018)
Abstract Human life develops and expands not only in time and space, but also in the retrograde permanent recollection and interweaving of memories. Therefore, individual human identity depends fully on a proper access to the autobiographical memory.
Externí odkaz:
https://doaj.org/article/c9884e8937714e68a7346b7ea4cfeb1a
Autor:
Chiara Posarelli, Michele Figus, Gloria Roberti, Sara Giammaria, Giorgio Ghirelli, Pierpaolo Quercioli, Tommaso Micelli Ferrari, Vincenzo Pace, Leonardo Mastropasqua, Luca Agnifili, Matteo Sacchi, Gianluca Scuderi, Andrea Perdicchi, Romeo Altafini, Maurizio Uva, Dino D’Andrea, Giuseppe Covello, Maria Novella Maglionico, Antonio Maria Fea, Carmela Carnevale, Francesco Oddone
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 18; Pages: 5320
Background The Italian XEN Glaucoma Treatment Registry (XEN-GTR) was created to acquire a comprehensive prospective dataset that includes the patient characteristics, intraoperative variables, and postoperative management of glaucoma patients undergo
Autor:
Andrea Russo, Teresio Avitabile, Maurizio Uva, Salvatore Faro, Livio Franco, Marisa Sanfilippo, Seby Gulisano, Mario Toro, Vittorio De Grande, Stefania Rametta, Laura Foti, Antonio Longo, Michele Reibaldi
Publikováno v:
Case Reports in Ophthalmology, Vol 3, Iss 1, Pp 71-76 (2012)
Purpose: To report the effective treatment of radiation macular edema following ruthenium-106 plaque brachytherapy for a choroidal melanoma with a dexamethasone 0.7-mg (Ozurdex®) intravitreal implant. Methods: An interventional case report with opti
Externí odkaz:
https://doaj.org/article/cd339eb1abfa417a940266606d78d6a0
Autor:
Silvia Bartollino, Flavia Chiosi, Silvio di Staso, Maurizio Uva, Arduino Pascotto, Michele Rinaldi, Jan M Keppel Hesselink, Ciro Costagliola, RINALDI, Michele
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 12, Pp 3485-3489 (2018)
Drug Design, Development and Therapy
Drug Design, Development and Therapy
Silvia Bartollino,1 Flavia Chiosi,1 Silvio di Staso,2 Maurizio Uva,3 Arduino Pascotto,1 Michele Rinaldi,4 Jan M Keppel Hesselink,5 Ciro Costagliola1 1Eye Clinic, Department of Medicine and Health Sciences “V. Tiberio,” University of Molise, Campo
Autor:
Topouzis1, F., Melamed2, S., DANESH MEYER3, H., Wells4, A. P., Kozobolis5, V., Wieland6, H., Andrew6, R., Wells6, D., THE INTERNATIONAL TRAVOPROST/TIMOLOL STUDY GROUP University Hospital of Alexandroupolis, Ophthalmic, Department, Kozobolis*, Greece: Vassilios P., George, Maskaleris, Efstathios Detorakis, • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece: Fotis Topouzis, Eleftherios, Anastasopoulos, Theofanis Pappas, • Ophthalmiatrio Hospital of Athens, Greece: Artemios Kandarakis, John Koutroumanos, • Associate Professor of Ophthalmology, Eye Clinic of the General University Hospital of Ioannina, Greece: Miltiadis Aspiotis, Chrisavgi Pappa, • General Hospital of Nikaia 'AG, Panteleimon, Pireous, ', Greece: Emmanuel Vaikoussis, Thrassyvoulos, Paschalidis, Panagiotis, Bournas, Nikos Kazatzis, • Eye Associates, Sydney, Nsw, Australia: Ivan Goldberg, Stuart, Graham, Paul Healey, • Eye Surgery Associates, East Melbourne VIC, • Suite 8, Australia: Julian Lockhart Rait, Lindfield, Nsw, Australia: Allan Bank*, • Western Sydney Eye Hospital, University, Clinic, Westmead, Hospital, Westmead, Nsw, Healey*, Australia: Paul R., Jonathan, Crowston, Magdalena, Guzowski, Ranier, Covar, Anne, Lee, Jen, Wan, Domit Azar, • Quai des Tanneries 26, • Marktplatz 3, Belgium: Paul Stadion, Eupen, Belgium: François Lizin*, • University Hospital Antwerp, Service of Ophthalmology, Belgium: Veva De Groot, Patrick, Schraepen, Bruno Reyntjens, • University Hospital Ghent, Ghent, Belgium: Anna Maria Kestelyn Stevens, Fien Witters, • Department of Ophthalmology, University of Tartu, Estonia: Pait Teesalu, Imbi, Kuus, Maris Oll, • Ida Tallinna Keskhaigla Silmakliinik, Tallinn, Estonia: Ulle Aamer, Elo, Alas, Marko Pastak, • Hopital Jean Minjoz, Service, D’Ophtalmologie, Besancon, Cedex, Delbosc* • Augenarzt, France: Bernard Y. C., Goeppingen, Germany: Albrecht Gerstenberger*, • Augenarzt, Mannheim, Germany: Peter Jungmann*, • Facharzt fuer Augenheilkunde, Starnberg, Hamacher*, Germany: Ludwig T., Ursula Hellmair •, M. u. e. n. c. h. e. n. e. r. s. t. r. 3., Weilheim, Bayer*, Germany: Andreas U. M., Wolfgang Foerster, • Marktplatz 34 36, Schorndorf, Germany: Thomas Christ*, • Dipartimento di Specialità Medico Chirurgiche dell’Università di Catania, Marta, Azienda Ospedaliera '. S., Emanuele, V., Ferrarotto, Catania, ', Italy: Alfredo Reibaldi, Maurizio, Uva, Antonio, Longo, Daniela Lombardo, • Policlinico San Matteo, Clinica, Oculistica, Pavia, Italy: Fernando Trimarchi, Giovanni, Milano, Antonella, Clemente, Gemma Rossi, M., Ilaria, Scatassi, Francesca Montemurro, • Clinica Oculistica, Università di Torino, Grignolo, Federico, Beatrice, Brogliatti, Rolle, Teresa, Cristina, Favero, Elisabetta, Giacosa, Angela Fornero, • Goldschleger Eye Institute, Sheba Medical Center, Tel, Hashomer, Israel: Shlomo Melamed, Mordehai, Goldenfeld, Hani, Verbin, Zohar, Vilner, Ran, Knaan, Iris Moroz, • Department of Ophthalmology, Carmel Medical Center, Haifa, Israel: Orna Geyer, Eitan Segev, • Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel, Aviv, Israel: Shimon Kurtz, Meira, Neudorfer, Gabi, Shemesh, Shiri Zayit, • Glaucoma Service, Outpatient, Department, Clinical Hospital 'Gailezers, Riga, ', Latvia: Lasma Volksone, Lija Karlsone, • Department of Ophthalmology, Riga Stradins University Hospital, Riga, Latvia: Guna Laganovska, Kristine, Baumane, Ilze Egite, • Eye Clinic, Kaunas University of Medicine, Kaunas, Lithuania: Ingrida Januleviciene, Loreta Kuzmiene, • Eye Institute, Remuera, Auckland, New Zealand: Helen Danesh Meyer*, • Eye Department, Wellington, Hospital, Wellington, Wells*, New Zealand: Anthony P., Andrew, Riley, Anthony, Bedggood, Helen, Long, Nina Ashraff, • Hospital Sao Jose, Servico de Oftalmologia, Lisbon, Abrantes*, Portugal: Pedro A. L., Maria, Reina, Jose Pedro Silva, Joao Ilharco, • Department of Ophthalmology, National University Hospital, Singapore: Paul Tec Kwan Chew, Lennard, Thean, Lim Boon Ang, Joseph, Manuel, Loon Seng Chee, Clement, Tan, Yeong Suet Ming, • Singapore National Eye Centre, Singapore: Steve Kah Leng Seah, Francis, Oen, Rahat, Husain, Hoh Sek Tian, Aung Tin, • Hospital Clinico San Carlos, Madrid, Spain: Julián Garcia Sánchez, Julián García Feijoo, José María Martínez de La Casa, Alfredo Castillo Gómez, • Hospital Universitario Miguel Servet, Consulta de Ojos, Zaragoza, Spain: Francisco Manuel Honrubia López, Vicente Polo Llorens, Luis Pablo Júlvez, Maria Luisa Gómez Martínez, José Manuel Larrosa Póvez, • Fundación Hospital Alcorcón, Servicio de Oftalmología, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain: Alfonso Arias Puente, Carmen, Carrasco, Maria del Carmen, García, Yolanda, Andrés Alba, • Hospital Universitario La Princesa, Spain: Elena Gurdiel, Emilio, Dorronzoro, Maria Jesús Muniesa, • Department of Ophthalmology, Tri Service General Hospital, Taipei, Taiwan: Da Wen Lu*, • Consultant Ophthalmologist, Arrowe Park Hospital, Wirral, Merseyside, Clearkin*, UK: Louis G., Yogesh, Patwala
Publikováno v:
European journal of ophthalmology. 17(2)
Purpose The objective of the study was to compare the intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004%/timolol 0.5% ophthalmic solution (Trav/Tim) to latanoprost 0.005%/timolol 0.5% ophthalmic solution (Lat/Tim), dosed onc